A detailed history of Candriam S.C.A. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Candriam S.C.A. holds 212,410 shares of BDX stock, worth $48.3 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
212,410
Previous 241,017 11.87%
Holding current value
$48.3 Million
Previous $56.3 Million 9.08%
% of portfolio
0.3%
Previous 0.35%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$221.47 - $242.41 $6.34 Million - $6.93 Million
-28,607 Reduced 11.87%
212,410 $51.2 Million
Q2 2024

Aug 05, 2024

BUY
$225.07 - $246.17 $713,922 - $780,851
3,172 Added 1.33%
241,017 $56.3 Million
Q1 2024

May 03, 2024

BUY
$233.45 - $247.73 $33.9 Million - $36 Million
145,418 Added 157.33%
237,845 $58.9 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $2.01 Million - $2.31 Million
-8,641 Reduced 8.55%
92,427 $22.5 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $1.36 Million - $1.51 Million
-5,337 Reduced 5.02%
101,068 $26.1 Million
Q2 2023

Aug 08, 2023

BUY
$238.39 - $265.32 $6.87 Million - $7.64 Million
28,803 Added 37.12%
106,405 $28.1 Million
Q1 2023

May 12, 2023

BUY
$229.71 - $259.35 $4.45 Million - $5.02 Million
19,357 Added 33.23%
77,602 $19.2 Million
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $3.29 Million - $3.88 Million
-15,089 Reduced 20.58%
58,245 $14.8 Million
Q3 2022

Nov 10, 2022

BUY
$51.03 - $264.23 $1.24 Million - $6.41 Million
24,257 Added 49.43%
73,334 $16.3 Million
Q2 2022

Aug 03, 2022

SELL
$234.74 - $275.42 $216,665 - $254,212
-923 Reduced 1.85%
49,077 $12.1 Million
Q1 2022

May 13, 2022

SELL
$243.64 - $270.48 $3.3 Million - $3.67 Million
-13,560 Reduced 21.33%
50,000 $13.3 Million
Q4 2021

Feb 10, 2022

SELL
$230.08 - $250.94 $127,694 - $139,271
-555 Reduced 0.87%
63,560 $16 Million
Q2 2021

Jul 20, 2021

BUY
$232.65 - $254.58 $4.9 Million - $5.36 Million
21,070 Added 48.95%
64,115 $15.6 Million
Q4 2020

Jan 22, 2021

SELL
$221.92 - $245.94 $1.55 Million - $1.71 Million
-6,965 Reduced 13.93%
43,045 $10.8 Million
Q3 2020

Oct 19, 2020

SELL
$215.77 - $276.76 $1,078 - $1,383
-5 Reduced 0.01%
50,010 $11.6 Million
Q2 2020

Jul 23, 2020

SELL
$219.9 - $263.41 $2.9 Million - $3.48 Million
-13,193 Reduced 20.87%
50,015 $12 Million
Q4 2019

Jan 21, 2020

BUY
$236.45 - $266.82 $640,543 - $722,815
2,709 Added 4.48%
63,208 $17,000
Q3 2019

Oct 21, 2019

BUY
$230.58 - $256.08 $227,121 - $252,238
985 Added 1.66%
60,499 $15,000
Q2 2019

Aug 01, 2019

BUY
$217.4 - $246.08 $757,421 - $857,342
3,484 Added 6.22%
59,514 $14.9 Million
Q1 2019

May 02, 2019

SELL
$206.05 - $248.17 $142,174 - $171,237
-690 Reduced 1.22%
56,030 $14 Million
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $102,774 - $129,480
502 Added 0.89%
56,720 $12.8 Million
Q3 2018

Nov 07, 2018

BUY
$233.07 - $256.0 $831,593 - $913,408
3,568 Added 6.78%
56,218 $14.7 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $897,743 - $1.01 Million
-4,314 Reduced 7.57%
52,650 $12.6 Million
Q1 2018

May 09, 2018

BUY
$205.46 - $240.27 $352,158 - $411,822
1,714 Added 3.1%
56,964 $12.3 Million
Q4 2017

Feb 07, 2018

SELL
$189.0 - $222.64 $55,566 - $65,456
-294 Reduced 0.53%
55,250 $11.8 Million
Q3 2017

Nov 03, 2017

BUY
$186.89 - $198.9 $10.4 Million - $11 Million
55,544
55,544 $10.9 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.